The near term future, page-110

For clarity, below is the "improved healing" study with HMRI that I was referring to in my previous post:

Houston Methodist Research Institute (HMRI)

• AVITA Medical Establishes Proof of Concept for Novel Treatments Using Genetically-Modified Skin Cells
• “Work is ongoing to characterize the tissue to identify functional attributes associated with rejuvenated skin.” – 2023 annual report.
• Investor Briefing - 1 March 2023 (Post #: 66560492):
• What they noticed in the preclinical animal study with HMRI: “when looking closer at the data, what we see is more rapid healing as one of the most compelling very near term achievable, potentially, benefits.”
• They’re currently developing an animal model study to demonstrate improved healing – it will take at least a couple of quarters to finalise (September 2023?). “If we’re able to demonstrate that improved healing, which is what we believe, we would develop a study for FDA that would allow us to make that claim because improved healing is the “Holy Grail”, so to speak, of wound care.” - JC (36min)

Is anyone else excited to hear more about the above later this year?